Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Kirk Randal J
Relationship:   10% Owner
City:   Radford
State:   VA
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   3,684,697    

Indirect Shares

   67,796,291      
Direct Value   $162,038,028    

Indirect Value

   $374,282,250      
Total Shares   71,480,988      
Total Value   $536,320,277      


Halozyme Therapeutics Inc $162,017,406 Alaunos Therapeutics $20,621 Halozyme Therapeutics Inc $162,017,406 Alaunos Therapeutics $20,621
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    14   
    0    

     Stock price went up :
    6   
    0    
     Stock price went down :
    8   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   46.5%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Clinical Data Inc CLDA Director, 10% Owner 2011-04-12 0 2011-04-12 0    Premium*  
            Halozyme Therapeutics Inc HALO 10% Owner 2018-08-28 3,562,388 2018-08-28 6,629,464    Premium*  
            Precipio Inc PRPO 10% Owner 2012-02-03 0 2018-08-28 27,151    Premium*  
            Precigen Inc PGEN 0 2024-05-02 51,557,665    Premium*  
            Alaunos Therapeutics TCRT Director, 10% Owner 2015-12-31 122,309 2015-12-31 9,570,094    Premium*  
            Aquabounty Technologies, Inc. AQB 10% Owner 2020-02-13 0 2020-12-17 11,917    Premium*  
* Premium Members only  

Records found :    271         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 6 of 11
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
PGEN Precigen Inc Chief Executive Officer   •       •       •   2018-08-31 4 A $13.74 $999,984 I/I 71,227 15,963,964 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-05-24 4 B $4.68 $338,972 I/I 72,430 985,177 2.64 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2018-10-31 4 A $11.56 $999,992 I/I 72,779 15,992,879 0 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2006-09-13 4 B $2.50 $185,000 I/I 74,000 658,300 1.5 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2018-02-28 4 A $13.02 $999,985 I/I 74,097 14,764,949 0 -
PGEN Precigen Inc Executive Chairman   •       •       •   2020-03-31 4 A $2.61 $199,999 I/I 76,628 10,588,601 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2017-11-30 4 A $12.65 $999,988 I/I 77,903 13,508,864 0 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2006-12-11 4 B $6.16 $492,800 I/I 80,000 1,262,000 1.5 -
PGEN Precigen Inc Director   –       •       •   2023-03-09 4 A $1.17 $100,000 I/I 85,470 31,337,786 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-05-23 4 B $4.67 $400,453 I/I 85,750 970,691 2.64 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2012-06-04 4 B $7.37 $660,691 I/I 89,646 328,663 2.25 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-05-21 4 B $4.74 $428,188 I/I 90,335 148,817 2.64 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-05-31 4 B $4.78 $432,246 I/I 90,428 1,069,299 2.64 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-05-17 4 B $4.69 $425,824 I/I 90,794 145,885 2.64 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2018-08-15 4 S $17.15 $1,569,928 I/I (91,541) 3,041,722 0 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2006-08-24 4 B $2.50 $233,250 I/I 93,300 304,400 1.5 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2006-08-17 4 B $2.46 $231,486 I/I 94,100 170,800 1.5 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2018-08-16 4 S $17.24 $1,644,058 I/I (95,363) 2,985,054 0 -
PGEN Precigen Inc   –       •       •   2023-12-28 4 B $1.41 $136,327 I/I 96,686 1,096,686 0.01 %
PGEN Precigen Inc Chief Executive Officer   •       •       •   2018-11-30 4 A $0.00 $0 I/I 98,002 16,013,287 0 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2012-06-01 4 B $7.39 $732,201 I/I 99,080 283,840 2.25 -
CLDA Clinical Data Inc Director   –       •       •   2006-05-18 4 B $20.00 $2,000,000 I/I 100,000 366,246 2.25 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2006-09-15 4 B $2.50 $256,250 I/I 102,500 780,800 1.5 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2018-08-24 4 S $18.20 $1,881,370 I/I (103,372) 2,219,466 0 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2018-07-25 4 S $17.32 $1,799,548 I/I (103,900) 3,734,865 0 -
  271  Records found
  1   2   3   4   5   6  7   8   9   10   11      
  Page 6 of 11  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us